AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCulloch, M.
Right arrow Articles by Colford, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCulloch, M.
Right arrow Articles by Colford, J. M., Jr
Related Collections
Right arrow Hepatitis
Right arrow Other Statistics/Evaluation/Research
October 2002, Vol 92, No. 10 | American Journal of Public Health 1619-1628
© 2002 American Public Health Association


RESEARCH AND PRACTICE

Chinese Herbal Medicine and Interferon in the Treatment of Chronic Hepatitis B: A Meta-Analysis of Randomized, Controlled Trials

Michael McCulloch, LAc, MPH, Michael Broffman, LAc, Jin Gao, MD, PhD and John M. Colford, Jr, MD, PhD

Michael McCulloch and Michael Broffman are with the Pine Street Clinic, San Anselmo, Calif. Michael McCulloch and Jin Gao are with the Institute of Biophysics, China Academy of Sciences, Beijing, China. Michael McCulloch and John M. Colford Jr, are with the School of Public Health, University of California at Berkeley.

Correspondence: Requests for reprints should be sent to John M. Colford Jr, MD, PhD, UC Berkeley School of Public Health, 140 Warren Hall MC 7360, Berkeley, CA 94720 (e-mail: jcolford{at}socrates.berkeley.edu).

Objectives. This meta-analysis was conducted to examine the effectiveness of Chinese herbal medicine (either alone or with interferon alfa) in treating chronic hepatitis B.

Methods. We searched the TCMLARS, AMED, CISCOM, EMBASE, MEDLINE, and Cochrane Collaboration databases and then hand-searched the articles’ bibliographies.

Results. Chinese herbal medicine significantly increased seroreversion of HBsAg and was equivalent to interferon alfa in seroreversion of HBeAg and hepatitis B virus (HBV) DNA; Chinese herbal medicine combined with interferon alfa significantly increased seroreversion of HBsAg, HBeAg, and HBV DNA. The Chinese herbal medicine active component bufotoxin combined with interferon alfa significantly increased HBeAg and HBV DNA seroreversion. The Chinese herbal medicine active component kurorinone was equivalent to interferon alfa in seroreversion of HBeAg and HBV DNA.

Conclusions. Although the quality of existing studies was poor, these data suggest that further trials of Chinese Herbal Medicine and interferon in chronic hepatitis B infection are justified.




This article has been cited by other articles:


Home page
The Journal of the Royal Society for the Promotion of HealthHome page
S Au and S Hiew
Integrating Western medicine and Traditional Chinese Medicine in GP surgeries and the community: a review of two pilot schemes
The Journal of the Royal Society for the Promotion of Health, December 1, 2002; 122(4): 220 - 225.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Public Health Association